Glaxo and Genmab drop IV version of MS immune drug
Glaxo and Genmab drop IV version of MS immune drug
GlaxoSmithKline PLC and Genmab A/S will end the development of an intravenous form of a drug intended to treat autoimmune diseases like lupus and multiple sclerosis, and focus on an injectable version.
The companies said an injectable version of Arzerra (ofatumumab) should be more convenient for patients and have fewer side effects. The drug can also be used to treat rheumatoid arthritis...Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1397
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 1 Replies
- 1833 Views
-
Last post by goellerc
-
- 0 Replies
- 1134 Views
-
Last post by ElliotB
-
- 61 Replies
- 13755 Views
-
Last post by jimmylegs
-
- 3 Replies
- 4997 Views
-
Last post by NHE
-
- 5 Replies
- 14025 Views
-
Last post by gibbledygook
-
- 1 Replies
- 1561 Views
-
Last post by ElliotB
-
- 0 Replies
- 1016 Views
-
Last post by DIM
-
- 0 Replies
- 480 Views
-
Last post by NHE
-
- 0 Replies
- 1659 Views
-
Last post by NHE